authorization as a facility user for animal experimentation for our recently acquired BSL-3 facility

We are proud to announce that we have received authorization as a facility user for animal experimentation for our recently acquired BSL-3 facility!

We are now one step closer to making our BSL-3 operational, paving the way for new interesting perspectives in our research.

This facility aims to become one of the points of reference in Italy and Europe for those who carry out research against pathogens that require a secure and adequate infrastructure for testing.

Alongside our in-house DNA vaccine manufacturing facility, the BSL-3 module is set to emerge as a pivotal infrastructure for the development of large-scale production and testing processes for genetic vaccines.

We thank our own laura luberto, Fabiana Fosca Ferrara, Monica Fraternali, and Lucrezia Pacello, whose invaluable support has made this important milestone possible.

Follow us to stay updated on our deployment of this technology!